Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.

IF 11.3 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Hemlata Jangir, Isheeta Ahuja, Shipra Agarwal, Vishesh Jain, Jagdish Prasad Meena, Sandeep Agarwala, Rajni Sharma, Mehar Chand Sharma, Venkateswaran K Iyer, Kalaivani Mani
{"title":"Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.","authors":"Hemlata Jangir,&nbsp;Isheeta Ahuja,&nbsp;Shipra Agarwal,&nbsp;Vishesh Jain,&nbsp;Jagdish Prasad Meena,&nbsp;Sandeep Agarwala,&nbsp;Rajni Sharma,&nbsp;Mehar Chand Sharma,&nbsp;Venkateswaran K Iyer,&nbsp;Kalaivani Mani","doi":"10.1007/s12022-023-09767-z","DOIUrl":null,"url":null,"abstract":"<p><p>Adrenocortical neoplasms are rare in childhood. Their histopathological categorization into benign and malignant is often challenging, impacting further management. While the AFIP/Wieneke scoring system is widely used for the prognostic classification of these tumors, it has limitations. Few other tumor scoring systems have evolved over the past few years. These have been validated in adults but not yet in pediatric patients. We evaluated a cohort of pediatric adrenocortical neoplasms to assess the applicability of AFIP/Wieneke criteria and the recently introduced Helsinki score and reticulin algorithm in predicting clinical outcomes. A tumor was considered 'clinically aggressive' in the presence of any of the following: metastases, recurrence, progressive disease, or death due to disease. Cases without any such event were considered 'clinically good'. Event-free survival time was the duration from the date of clinical presentation to any post-operative adverse event. For overall survival analysis, the endpoint was either the last follow-up or death due to disease.Using ROC curve analysis, the obtained cut-off Helsinki score of 24 could stratify the cases into two prognostically relevant groups. Survival analysis showed significant differences in the event-free and overall survival of these two groups of patients, validating the proposed cut-off. None of the three histopathological scoring systems could predict an unfavorable outcome with 100% accuracy. All showed a sensitivity of ≥ 80%, with the reticulin algorithm achieving 100% sensitivity. The specificity and accuracy of the AFIP/Wieneke criteria were the lowest (62.5% and 73.08%, respectively). While the Helsinki score (at the cut-off score of 24) and the reticulin algorithm had similar accuracy rates (80.77%, and 80%, respectively), the specificity of the former was higher (81.25%) than the latter (68.75%). A separate analysis revealed that the Ki-67 index at a cut-off of 18% had a sensitivity of 80% and a specificity of 81.25% for predicting an unfavorable outcome.</p>","PeriodicalId":55167,"journal":{"name":"Endocrine Pathology","volume":"34 2","pages":"213-223"},"PeriodicalIF":11.3000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12022-023-09767-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

Adrenocortical neoplasms are rare in childhood. Their histopathological categorization into benign and malignant is often challenging, impacting further management. While the AFIP/Wieneke scoring system is widely used for the prognostic classification of these tumors, it has limitations. Few other tumor scoring systems have evolved over the past few years. These have been validated in adults but not yet in pediatric patients. We evaluated a cohort of pediatric adrenocortical neoplasms to assess the applicability of AFIP/Wieneke criteria and the recently introduced Helsinki score and reticulin algorithm in predicting clinical outcomes. A tumor was considered 'clinically aggressive' in the presence of any of the following: metastases, recurrence, progressive disease, or death due to disease. Cases without any such event were considered 'clinically good'. Event-free survival time was the duration from the date of clinical presentation to any post-operative adverse event. For overall survival analysis, the endpoint was either the last follow-up or death due to disease.Using ROC curve analysis, the obtained cut-off Helsinki score of 24 could stratify the cases into two prognostically relevant groups. Survival analysis showed significant differences in the event-free and overall survival of these two groups of patients, validating the proposed cut-off. None of the three histopathological scoring systems could predict an unfavorable outcome with 100% accuracy. All showed a sensitivity of ≥ 80%, with the reticulin algorithm achieving 100% sensitivity. The specificity and accuracy of the AFIP/Wieneke criteria were the lowest (62.5% and 73.08%, respectively). While the Helsinki score (at the cut-off score of 24) and the reticulin algorithm had similar accuracy rates (80.77%, and 80%, respectively), the specificity of the former was higher (81.25%) than the latter (68.75%). A separate analysis revealed that the Ki-67 index at a cut-off of 18% had a sensitivity of 80% and a specificity of 81.25% for predicting an unfavorable outcome.

Abstract Image

儿童肾上腺皮质肿瘤:比较三种组织病理学评分系统的研究。
肾上腺皮质肿瘤在儿童期是罕见的。他们的组织病理学分类为良性和恶性往往是具有挑战性的,影响进一步的管理。虽然AFIP/Wieneke评分系统被广泛用于这些肿瘤的预后分类,但它有局限性。在过去的几年中,很少有其他肿瘤评分系统得到发展。这些已在成人中得到证实,但尚未在儿科患者中得到证实。我们评估了一组儿童肾上腺皮质肿瘤,以评估AFIP/Wieneke标准以及最近引入的赫尔辛基评分和reticulin算法在预测临床结果方面的适用性。如果出现以下任何一种情况,肿瘤被认为具有“临床侵袭性”:转移、复发、疾病进展或因疾病死亡。没有任何此类事件的病例被认为是“临床良好”。无事件生存时间是指从临床表现到任何术后不良事件的持续时间。对于总生存分析,终点为最后一次随访或因病死亡。通过ROC曲线分析,得到的赫尔辛基分值为24分,可以将病例分为两个预后相关的组。生存分析显示,两组患者的无事件生存期和总生存期存在显著差异,验证了建议的截止日期。三种组织病理学评分系统都不能100%准确地预测不良结果。所有算法的灵敏度均≥80%,其中reticulin算法的灵敏度达到100%。AFIP/Wieneke标准的特异性和准确性最低(分别为62.5%和73.08%)。赫尔辛基评分(临界值为24)与reticulin算法准确率相近(分别为80.77%和80%),但前者的特异性(81.25%)高于后者(68.75%)。另一项分析显示,Ki-67指数在18%的临界值下预测不良预后的敏感性为80%,特异性为81.25%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine Pathology
Endocrine Pathology 医学-病理学
CiteScore
12.30
自引率
20.50%
发文量
41
审稿时长
>12 weeks
期刊介绍: Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信